public meeting: patient-focused drug development for breast cancer (part 2 of 2)
Published 3 years ago • 175 plays • Length 1:48:45Download video MP4
Download video MP3
Similar videos
-
1:53:07
public meeting: patient-focused drug development for breast cancer (part 1 of 2)
-
1:03:19
public meeting: patient-focused drug development for opioid use disorder - part 2
-
1:59:57
public meeting: patient-focused drug development for female sexual dysfunction (part 2 of 2)
-
1:54:32
public meeting: patient-focused drug development for autism (part 1 of 2)
-
2:18:58
public meeting: patient-focused drug development for female sexual dysfunction (part 1 of 2)
-
1:32:12
public meeting: patient-focused drug development for chagas disease (part 1 of 4)
-
59:34
public meeting on patient focused drug development for hiv part 2
-
5:32
sabcs snippets: the us fda approval of ribociclib
-
1:39:37
public meeting on patient focused drug development for lung cancer part 1
-
2:08:17
public meeting: patient-focused drug development for opioid use disorder - part 1
-
2:43:12
public meeting on patient focused drug development for sickle cell disease part 1
-
2:07:05
public meeting on patient focused drug development for narcolepsy part 1
-
3:37
what is patient-focused drug development (pfdd)?
-
9:21
fda patient focused drug development meeting - overview of fda pfdd initiative
-
1:56:32
public meeting on patient focused drug development for idiopathic pulmonary fibrosis part 1
-
9:00:31
september 26, 2024 meeting of the oncologic drugs advisory committee (odac)
-
8:03
dr. binita ashar - update on fda's activities on breast implants
-
5:31
fda d.i.s.c.o.: olaparib for gbrcam her2-negative metastatic breast cancer